跳至主要内容
临床试验/TCTR20131003001
TCTR20131003001已完成3 期

A randomized controlled trial of electroacupuncture at Body acupoints and Fenglong (ST 40) for regulating serum lipids in dyslipidemic patients in Thailand

Faculty of Medicine, SW0 个研究点目标入组 60 人开始时间: 2013年10月3日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 Years 至 65 Years(—)
性别
All

入选标准

  • Patients who were diagnosed with dyslipidemia (defined as triglycerides ≥ 150 mg/dL, or total cholesterol (TC) ≥ 200 mg/dL or HDL-cholesterol (HDL-C) < 40 mg/dL (men) or HDL-C < 50 mg/dL (women) or LDL-cholesterol (LDL-C) > 130 mg/dL) and were not taking any lipid-lowering drugs were invited to participate in the study.

排除标准

  • Patients who had a history of bleeding disorders or were receiving anticoagulant or anti-platelet aggregation medications, had epilepsy, uncontrolled hypertension, and active dermatological lesions at the area of acupuncture, as well as pregnant women or those patients whose mental disabilities made their participation in the study difficult were excluded from the study.

研究者

发起方
Faculty of Medicine&#44; SW

相似试验

Electroacupuncture at Body acupoints and Fenglong... | 临床试验